<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chow KW</submitter><funding>NCATS NIH HHS</funding><pagination>2389-2397</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11380462</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>68(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Hepatic encephalopathy (HE) is a major cause of mortality and morbidity in patients with cirrhosis. Lactulose non-adherence is one of the most frequently reported precipitants of hospital admission for HE.&lt;h4>Aims&lt;/h4>We aimed to identify which factors contribute most to lactulose non-adherence and propose strategies to promote greater adherence and utilization of lactulose.&lt;h4>Methods&lt;/h4>Participants in this study consisted of patients with cirrhosis who were taking lactulose for prevention of HE. Subjects were administered the Morisky Adherence Scale 8 (MAS-8) and a customized 16-question survey that assessed barriers to lactulose adherence. Results from the MAS-8 were used to stratify subjects into "adherent" and "non-adherent" groups. Survey responses were compared </pubmed_abstract><journal>Digestive diseases and sciences</journal><pubmed_title>Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.</pubmed_title><pmcid>PMC11380462</pmcid><funding_grant_id>UL1 TR001881</funding_grant_id><pubmed_authors>Ibrahim BM</pubmed_authors><pubmed_authors>Chen KT</pubmed_authors><pubmed_authors>Dang L</pubmed_authors><pubmed_authors>Chow KW</pubmed_authors><pubmed_authors>Dang A</pubmed_authors><pubmed_authors>Saab S</pubmed_authors><pubmed_authors>Jackson NJ</pubmed_authors><pubmed_authors>Yum JJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy.</name><description>&lt;h4>Background&lt;/h4>Hepatic encephalopathy (HE) is a major cause of mortality and morbidity in patients with cirrhosis. Lactulose non-adherence is one of the most frequently reported precipitants of hospital admission for HE.&lt;h4>Aims&lt;/h4>We aimed to identify which factors contribute most to lactulose non-adherence and propose strategies to promote greater adherence and utilization of lactulose.&lt;h4>Methods&lt;/h4>Participants in this study consisted of patients with cirrhosis who were taking lactulose for prevention of HE. Subjects were administered the Morisky Adherence Scale 8 (MAS-8) and a customized 16-question survey that assessed barriers to lactulose adherence. Results from the MAS-8 were used to stratify subjects into "adherent" and "non-adherent" groups. Survey responses were compared </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-05T14:38:36.871Z</modification><creation>2025-04-05T14:38:36.871Z</creation></dates><accession>S-EPMC11380462</accession><cross_references><pubmed>37119376</pubmed><doi>10.1007/s10620-023-07935-z</doi></cross_references></HashMap>